Weight control: how to read this selection
The "Weight Control" category brings together products with different substance names, brands and packaging formats. Here, tirzepatide, retatrutide, cagrilintide, AOD-9604, Tesamorelin, MOTS-c and products with NAD+ in the name can be compared. The query "peptides for weight loss" describes the search intent, but the category name is not a medical indication and does not confirm the result for a person. For comparison, it is important to separate the substance from the trade name and from the characteristics of the specific package.
What the category includes
Products with tirzepatide in the name
PeptoLabs has TirzeMax in vials labeled 10/30/60 mg and pens labeled 20/40/60 mg. Separately, the selection includes the Mounjaro Lilly syringe pen, Biopatid Biopell 60 mg/2 ml and Biopatid KIT 10 mg/2 ml, which contains six vials. These products cannot be reduced to one option only because of the mention of tirzepatide: the brand, format, declared quantity and configuration differ.
Retatrutide and kagrilintide
Retatrutide is presented by RetaSlim PeptoLabs: 10/30/60 mg vial and 20/40 mg pen. The same part of the catalog includes RetaCode Helixara 40 mg, Retatrutide Synedica 40 mg in a pen and Retatrutide Vigelan 20 mg in a pre-filled pen. The presence of these names in the catalog does not indicate the regulatory status of the product or who it is suitable for.
Cagrilintide is listed as PeptoLabs 10 mg individual vial, PeptoLabs 10/20 mg pen, and CagriCode Rx Helixara 20 mg. Cagri Reta Dual Pen Kit Synedica has two components in the name: Cagrilintide 4 mg and Retatrutide 40 mg. This is not a single-component product, so it should not be compared with a single vial by a single figure in milligrams.
Other products of the selection
The category also includes PeptoLabs AOD-9604 10mg, PeptoLabs Tesamorelin 10mg and a Biopell kit of two 10mg vials. MOTS-c is available as Biopell 15 mg, Helixara 20 mg/3 mL pen, and PeptoLabs 10/40 mg vial. NAD+ BioPell Pen Peptide is labeled 500 mg. Biotrutid Biopell is also included in the selection, but the name itself does not provide grounds for independently determining its composition.
Why the substance, trade name and packaging are distinct
TirzeMax, Biopatid, TirzeCode and the Munjaro pen have different trade names and are under different brand names. The designation "Mounjaro analogue" in the TirzeCode name is not sufficient reason to describe it as interchangeable with the Lilly product. Similarly, the close sounding of Biopatid and Biotrutid does not confirm the same active substance or composition. Such a conclusion requires data of a specific variant, and not the similarity of words.
Vial, pen and kit describe the package, not the medical scheme. The 10/30/60 mg marking may identify product variants, but does not mean a single dose. A multi-bottle set contains a different set than a single pen, so you should compare them first by composition and number of units, not by price or the total figure in the name.
How to compare specifications without assumptions
| Position | What the name states | What should be clarified |
|---|
| TirzeMax PeptoLabs | Vial 10/30/60 mg or pen syringe 20/40/60 mg | Characteristics of the selected option and storage conditions |
| Biopatid Biopell | 60 mg/2 ml or KIT 10 mg/2 ml with six vials | Full contents and the differences between specific options |
| Cagri Reta Dual Pen Kit Synedica | Cagrilintide 4 mg and retatrutide 40 mg in the name | Set options and information about each component |
| RetaSlim PeptoLabs | Vial 10/30/60 mg or pen 20/40 mg | Which format is selected, without transferring data between them |
The word "vial" in the name does not establish that the contents are powder or describe how the product is prepared for use. Even for options with the same substance in the card, the configuration, volume and storage conditions may differ. Therefore, data from one vial should not be transferred to another just because of a common brand or close labeling in milligrams.
The syringe pen is also not a standalone answer to questions about the product characteristics. From the name, you can establish the format and the declared amount when it is indicated, but do not draw from this an instruction or a conclusion about the concentration. For Retatrutide Synedica 40 mg and Retatrutide Vigelan 20 mg, it is appropriate to record the difference in brand and labeling, rather than considering one position as an older or younger version of the other.
For Biopatid, it is particularly important not to confuse the 60 mg/2 mL data with the KIT 10 mg/2 mL data. The set has six vials in the title, so the question about the number of units and the set is separate from the question about the substance. The same approach is needed with the Cagri Reta Dual Pen Kit: the presence of two component names does not tell how they should be used together.
Milligrams, milliliters, and number of packages answer different questions. First, check the full name and brand, then the form, declared quantity and composition. If the characteristic is not disclosed or the wording is ambiguous, you should not supplement it with assumptions.
Limits of information in the category
The range description does not establish a diagnosis, does not determine the dose, and does not replace the doctor's assessment. Nor does it confirm the efficacy, safety, sterility, origin or status of a particular product. In particular, retatrutide should not be presented as a standard approved treatment option simply because it has separate listings. Before ordering, check the marking of the selected option, information about the manufacturer, contents and storage conditions.
Where to continue the comparison
To compare MOTS-c and products with NAD+ in the name, go to the category Energy and stamina, where these products are considered in a different context. The full list of directions is available at Novavroda catalogue. Before placing an order, familiarize yourself with terms of delivery and payment.
